Why ImmunityBio Stock Is Trading Higher Thursday
The company announced insurance coverage of ANKTIVA, a immunotherapy used to treat non-muscle invasive bladder cancer that was unresponsive to other specific treatments.
Trump Could Cash Out $3.2B Stake In Namesake Media Company And Still Maintain Voting Control
Donald Trump could sell his stake in his namesake media company according to a new filing from Trump Media & Technology Group.
What’s Going On With Broadcom Stock Thursday?
Broadcom on Thursday announced that its Symantec Cloud Secure Web Gateway solution received Federal Risk and Authorization Management Program (FedRAMP) authorization. The company said the solution enables U.S. federal agencies to migrate security services from on-premises data centers to cloud-native services cost-effectively without sacrificing security or designing new workflows.
Why MGO Global Stock Is Soaring
MGO Global shares are trading higher Thursday after the company announced it has entered into an agreement for a business combination with Heidmar, Inc. Here's a look at what to know:
What Is Going On With Emergent BioSolutions Shares?
On Thursday prior to the market open, Emergent BioSolutions announced it entered into a definitive agreement with Bora to sell the site for about $30 million.
12 Consumer Discretionary Stocks Moving In Thursday’s Intraday Session
Gainers Allurion Technologies (NYSE:ALUR) shares increased by 152.8% to $2.68 during Thursday’s regular session. The company’s market cap…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Molecular Partners (NASDAQ:MOLN) stock rose 39.1% to $11.07 during Thursday’s regular session. The market value of their…
12 Industrials Stocks Moving In Thursday’s Intraday Session
Gainers Nano Nuclear Energy (NASDAQ:NNE) stock rose 28.8% to $14.95 during Thursday’s regular session. The company’s market cap…
12 Information Technology Stocks Moving In Thursday’s Intraday Session
Gainers SMX (Security Matters) (NASDAQ:SMX) stock moved upwards by 29.9% to $0.15 during Thursday’s regular session. The market…
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo.